

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 5.89937818 |
| 2 | DNA deamination (GO:0045006) | 4.74744082 |
| 3 | ribosomal small subunit biogenesis (GO:0042274) | 4.39880701 |
| 4 | viral transcription (GO:0019083) | 4.28174027 |
| 5 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.24239125 |
| 6 | respiratory chain complex IV assembly (GO:0008535) | 4.21825029 |
| 7 | cotranslational protein targeting to membrane (GO:0006613) | 4.21534719 |
| 8 | protein targeting to ER (GO:0045047) | 4.14477639 |
| 9 | signal peptide processing (GO:0006465) | 4.12682285 |
| 10 | translational termination (GO:0006415) | 4.09876077 |
| 11 | protein neddylation (GO:0045116) | 4.08138491 |
| 12 | negative regulation of mast cell activation (GO:0033004) | 4.07247503 |
| 13 | protein localization to endoplasmic reticulum (GO:0070972) | 4.00431897 |
| 14 | protein complex biogenesis (GO:0070271) | 3.96441735 |
| 15 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.92462104 |
| 16 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.91847899 |
| 17 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.90080490 |
| 18 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.90080490 |
| 19 | NADH dehydrogenase complex assembly (GO:0010257) | 3.90080490 |
| 20 | cytochrome complex assembly (GO:0017004) | 3.85259309 |
| 21 | autophagic vacuole fusion (GO:0000046) | 3.81693557 |
| 22 | cellular biogenic amine catabolic process (GO:0042402) | 3.80580051 |
| 23 | amine catabolic process (GO:0009310) | 3.80580051 |
| 24 | kynurenine metabolic process (GO:0070189) | 3.73114778 |
| 25 | proteasome assembly (GO:0043248) | 3.70327308 |
| 26 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.63595314 |
| 27 | termination of RNA polymerase III transcription (GO:0006386) | 3.63595314 |
| 28 | indolalkylamine catabolic process (GO:0046218) | 3.57922032 |
| 29 | tryptophan catabolic process (GO:0006569) | 3.57922032 |
| 30 | indole-containing compound catabolic process (GO:0042436) | 3.57922032 |
| 31 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.56937389 |
| 32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.55398766 |
| 33 | chaperone-mediated protein transport (GO:0072321) | 3.53069531 |
| 34 | translational elongation (GO:0006414) | 3.52131639 |
| 35 | sequestering of actin monomers (GO:0042989) | 3.47172711 |
| 36 | organelle membrane fusion (GO:0090174) | 3.45923048 |
| 37 | negative regulation of interleukin-12 production (GO:0032695) | 3.44732706 |
| 38 | regulation of mononuclear cell migration (GO:0071675) | 3.43829958 |
| 39 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.40573358 |
| 40 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.38529955 |
| 41 | maturation of SSU-rRNA (GO:0030490) | 3.36855203 |
| 42 | viral life cycle (GO:0019058) | 3.31137546 |
| 43 | endosome to pigment granule transport (GO:0043485) | 3.30036199 |
| 44 | endosome to melanosome transport (GO:0035646) | 3.30036199 |
| 45 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.29376441 |
| 46 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.27412626 |
| 47 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.27412626 |
| 48 | peptidyl-histidine modification (GO:0018202) | 3.27125120 |
| 49 | positive regulation of defense response to virus by host (GO:0002230) | 3.26432300 |
| 50 | platelet dense granule organization (GO:0060155) | 3.25877729 |
| 51 | cellular protein complex disassembly (GO:0043624) | 3.25081769 |
| 52 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.21743732 |
| 53 | behavioral response to nicotine (GO:0035095) | 3.21243180 |
| 54 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.20019362 |
| 55 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.18391479 |
| 56 | protein deneddylation (GO:0000338) | 3.18163382 |
| 57 | regulation of metalloenzyme activity (GO:0048552) | 3.16507626 |
| 58 | cullin deneddylation (GO:0010388) | 3.16146089 |
| 59 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.15113276 |
| 60 | glycerophospholipid catabolic process (GO:0046475) | 3.12037286 |
| 61 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.11807145 |
| 62 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.11731569 |
| 63 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.11731569 |
| 64 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.10986826 |
| 65 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.10986826 |
| 66 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.10986826 |
| 67 | negative regulation of interleukin-1 production (GO:0032692) | 3.09678236 |
| 68 | translation (GO:0006412) | 3.09116468 |
| 69 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.06975546 |
| 70 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.05337348 |
| 71 | mannosylation (GO:0097502) | 3.04206918 |
| 72 | cellular response to ATP (GO:0071318) | 3.02333876 |
| 73 | response to interferon-beta (GO:0035456) | 3.01595166 |
| 74 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.97711399 |
| 75 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.96025702 |
| 76 | regulation of chronic inflammatory response (GO:0002676) | 2.94783694 |
| 77 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.93592544 |
| 78 | ATP synthesis coupled proton transport (GO:0015986) | 2.93592544 |
| 79 | RNA capping (GO:0036260) | 2.91759886 |
| 80 | 7-methylguanosine RNA capping (GO:0009452) | 2.91759886 |
| 81 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.91604922 |
| 82 | 7-methylguanosine mRNA capping (GO:0006370) | 2.91133974 |
| 83 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.90991829 |
| 84 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.90991829 |
| 85 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.90617029 |
| 86 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.89803154 |
| 87 | negative regulation of ligase activity (GO:0051352) | 2.88923309 |
| 88 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.88923309 |
| 89 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.87368779 |
| 90 | ribosomal large subunit biogenesis (GO:0042273) | 2.85961060 |
| 91 | positive regulation of mast cell activation (GO:0033005) | 2.85502456 |
| 92 | translational initiation (GO:0006413) | 2.84617297 |
| 93 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.84085517 |
| 94 | eosinophil chemotaxis (GO:0048245) | 2.81551372 |
| 95 | GTP biosynthetic process (GO:0006183) | 2.81498939 |
| 96 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.81325510 |
| 97 | granulocyte activation (GO:0036230) | 2.80882986 |
| 98 | tryptophan metabolic process (GO:0006568) | 2.80233091 |
| 99 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.78839908 |
| 100 | respiratory electron transport chain (GO:0022904) | 2.78561581 |
| 101 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.78457672 |
| 102 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.77502443 |
| 103 | cellular component biogenesis (GO:0044085) | 2.76717869 |
| 104 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.75905826 |
| 105 | protein targeting to membrane (GO:0006612) | 2.74021631 |
| 106 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.73972783 |
| 107 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.72022163 |
| 108 | electron transport chain (GO:0022900) | 2.71826929 |
| 109 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.71635993 |
| 110 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.71032159 |
| 111 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.69626718 |
| 112 | neutrophil activation involved in immune response (GO:0002283) | 2.69621906 |
| 113 | protein complex disassembly (GO:0043241) | 2.68500343 |
| 114 | adhesion of symbiont to host cell (GO:0044650) | 2.67733100 |
| 115 | virion attachment to host cell (GO:0019062) | 2.67733100 |
| 116 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.67160540 |
| 117 | aerobic respiration (GO:0009060) | 2.65975611 |
| 118 | N-acetylneuraminate metabolic process (GO:0006054) | 2.65487952 |
| 119 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.65122092 |
| 120 | indolalkylamine metabolic process (GO:0006586) | 2.64712826 |
| 121 | regulation of mast cell activation (GO:0033003) | 2.63355591 |
| 122 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.61843330 |
| 123 | daunorubicin metabolic process (GO:0044597) | 2.61712314 |
| 124 | polyketide metabolic process (GO:0030638) | 2.61712314 |
| 125 | doxorubicin metabolic process (GO:0044598) | 2.61712314 |
| 126 | positive regulation of prostaglandin secretion (GO:0032308) | 2.61355141 |
| 127 | metallo-sulfur cluster assembly (GO:0031163) | 2.61110089 |
| 128 | iron-sulfur cluster assembly (GO:0016226) | 2.61110089 |
| 129 | macromolecular complex disassembly (GO:0032984) | 2.60281347 |
| 130 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.59494668 |
| 131 | regulation of hypersensitivity (GO:0002883) | 2.59088981 |
| 132 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.58957498 |
| 133 | GPI anchor biosynthetic process (GO:0006506) | 2.58828111 |
| 134 | amino sugar catabolic process (GO:0046348) | 2.58732168 |
| 135 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.58486973 |
| 136 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.58486973 |
| 137 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.57438640 |
| 138 | superoxide anion generation (GO:0042554) | 2.57304455 |
| 139 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.56152359 |
| 140 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.55878662 |
| 141 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.54890026 |
| 142 | regulation of defense response to virus by host (GO:0050691) | 2.53303042 |
| 143 | telomere maintenance via recombination (GO:0000722) | 2.52571958 |
| 144 | cellular response to interferon-beta (GO:0035458) | 2.51614356 |
| 145 | lysosome organization (GO:0007040) | 2.50912443 |
| 146 | lytic vacuole organization (GO:0080171) | 2.50912443 |
| 147 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.50639826 |
| 148 | positive regulation of mast cell degranulation (GO:0043306) | 2.50639826 |
| 149 | keratan sulfate catabolic process (GO:0042340) | 2.50350862 |
| 150 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.50113017 |
| 151 | cellular response to exogenous dsRNA (GO:0071360) | 2.49761795 |
| 152 | GDP-mannose metabolic process (GO:0019673) | 2.49527924 |
| 153 | aromatic amino acid family catabolic process (GO:0009074) | 2.48879531 |
| 154 | eosinophil migration (GO:0072677) | 2.48613823 |
| 155 | CTP metabolic process (GO:0046036) | 2.48207695 |
| 156 | CTP biosynthetic process (GO:0006241) | 2.48207695 |
| 157 | immunoglobulin mediated immune response (GO:0016064) | 2.47648846 |
| 158 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.46926562 |
| 159 | regulation of prostaglandin secretion (GO:0032306) | 2.45513587 |
| 160 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.44960486 |
| 161 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.44513296 |
| 162 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.43971027 |
| 163 | intracellular pH reduction (GO:0051452) | 2.42343826 |
| 164 | negative regulation of telomere maintenance (GO:0032205) | 2.41831891 |
| 165 | regulation of chemokine biosynthetic process (GO:0045073) | 2.41083328 |
| 166 | negative regulation of monooxygenase activity (GO:0032769) | 2.41077350 |
| 167 | positive regulation of antigen processing and presentation (GO:0002579) | 2.40233498 |
| 168 | NAD biosynthetic process (GO:0009435) | 2.39928983 |
| 169 | neutrophil activation (GO:0042119) | 2.39265779 |
| 170 | regulation of antigen processing and presentation (GO:0002577) | 2.38223044 |
| 171 | regulation of monocyte chemotaxis (GO:0090025) | 2.37555452 |
| 172 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.37542064 |
| 173 | monocyte chemotaxis (GO:0002548) | 2.34736538 |
| 174 | negative regulation of lipid storage (GO:0010888) | 2.33730494 |
| 175 | phagosome maturation (GO:0090382) | 2.31634708 |
| 176 | angiogenesis involved in wound healing (GO:0060055) | 2.31326219 |
| 177 | response to xenobiotic stimulus (GO:0009410) | 2.30462646 |
| 178 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.29737475 |
| 179 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.27990066 |
| 180 | low-density lipoprotein particle clearance (GO:0034383) | 2.27889706 |
| 181 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 2.27833721 |
| 182 | regulation of T-helper 1 type immune response (GO:0002825) | 2.27748367 |
| 183 | negative regulation of protein secretion (GO:0050709) | 2.26818507 |
| 184 | oligosaccharide catabolic process (GO:0009313) | 2.26016814 |
| 185 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.25796155 |
| 186 | positive regulation of T cell apoptotic process (GO:0070234) | 2.25592466 |
| 187 | positive regulation of heat generation (GO:0031652) | 2.25489884 |
| 188 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.24586667 |
| 189 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.23223011 |
| 190 | regulation of platelet activation (GO:0010543) | 2.22116757 |
| 191 | plasma lipoprotein particle clearance (GO:0034381) | 2.21331502 |
| 192 | regulation of interleukin-8 secretion (GO:2000482) | 2.18344020 |
| 193 | glycosphingolipid catabolic process (GO:0046479) | 2.17299653 |
| 194 | negative regulation of cytokine secretion (GO:0050710) | 2.16286699 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.18412998 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.16061014 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.84119915 |
| 4 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.66420328 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.53049770 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.45118761 |
| 7 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.38785597 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.35794061 |
| 9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.32278416 |
| 10 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.09057621 |
| 11 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.91726809 |
| 12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.85283357 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.74088522 |
| 14 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.72318215 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.71875817 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.67564786 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 2.65234718 |
| 18 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.63629524 |
| 19 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.58370107 |
| 20 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.54924605 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.40441559 |
| 22 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.37802629 |
| 23 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.36784163 |
| 24 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.36448531 |
| 25 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.33333737 |
| 26 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.32688326 |
| 27 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.29514877 |
| 28 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.24929157 |
| 29 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.24664192 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.22578897 |
| 31 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.22041420 |
| 32 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.19997428 |
| 33 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.16925778 |
| 34 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.16851304 |
| 35 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.06764250 |
| 36 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.06398246 |
| 37 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.02101048 |
| 38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.01065387 |
| 39 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.97517611 |
| 40 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.96256806 |
| 41 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.93203453 |
| 42 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.93162305 |
| 43 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90341238 |
| 44 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.90144614 |
| 45 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.86074695 |
| 46 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.80528926 |
| 47 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.76549900 |
| 48 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.74077753 |
| 49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.72092417 |
| 50 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.69224998 |
| 51 | GATA3_26560356_Chip-Seq_TH2_Human | 1.69143264 |
| 52 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.67576709 |
| 53 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.62502047 |
| 54 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.61854384 |
| 55 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.61435118 |
| 56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61142579 |
| 57 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.61115279 |
| 58 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60783897 |
| 59 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.59244023 |
| 60 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.58852096 |
| 61 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.58726210 |
| 62 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.54137637 |
| 63 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51757721 |
| 64 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.51265060 |
| 65 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.50808845 |
| 66 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.50015687 |
| 67 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.48263822 |
| 68 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.48217118 |
| 69 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.47367666 |
| 70 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44282957 |
| 71 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43694758 |
| 72 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.43401748 |
| 73 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.42320355 |
| 74 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42036009 |
| 75 | AR_20517297_ChIP-Seq_VCAP_Human | 1.39735337 |
| 76 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.39510684 |
| 77 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.37530430 |
| 78 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.33279320 |
| 79 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.31800524 |
| 80 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.31028520 |
| 81 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.30489127 |
| 82 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.28437477 |
| 83 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27817816 |
| 84 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.26996026 |
| 85 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.26996026 |
| 86 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.26797788 |
| 87 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.26521878 |
| 88 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.26485950 |
| 89 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.26182099 |
| 90 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25651090 |
| 91 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19982944 |
| 92 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.19327297 |
| 93 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18328456 |
| 94 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.17882200 |
| 95 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.17882200 |
| 96 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.16780820 |
| 97 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.16377261 |
| 98 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14911334 |
| 99 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14411317 |
| 100 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.13181791 |
| 101 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.11763876 |
| 102 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.11346728 |
| 103 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.10565979 |
| 104 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.09693421 |
| 105 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09572566 |
| 106 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 1.09564795 |
| 107 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.09474502 |
| 108 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.08086373 |
| 109 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.07664292 |
| 110 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.07626870 |
| 111 | CJUN_26792858_Chip-Seq_BT549_Human | 1.05013917 |
| 112 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.02999987 |
| 113 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.02640822 |
| 114 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02509307 |
| 115 | P300_19829295_ChIP-Seq_ESCs_Human | 1.01413116 |
| 116 | SPI1_23127762_ChIP-Seq_K562_Human | 1.01233786 |
| 117 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.00588042 |
| 118 | NCOR_22424771_ChIP-Seq_293T_Human | 1.00474266 |
| 119 | * ERA_21632823_ChIP-Seq_H3396_Human | 1.00029096 |
| 120 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98839865 |
| 121 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98839865 |
| 122 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.97811920 |
| 123 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97720592 |
| 124 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.96802900 |
| 125 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.96049918 |
| 126 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.95998455 |
| 127 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95778028 |
| 128 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.95516085 |
| 129 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.94991458 |
| 130 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.93121879 |
| 131 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.93018603 |
| 132 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92488489 |
| 133 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.92099793 |
| 134 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.91962272 |
| 135 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.91801684 |
| 136 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90048065 |
| 137 | GATA3_26560356_Chip-Seq_TH1_Human | 0.90029109 |
| 138 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.89997342 |
| 139 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.88861987 |
| 140 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.88842755 |
| 141 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.88422732 |
| 142 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.88013719 |
| 143 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.87279763 |
| 144 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86790197 |
| 145 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.86645462 |
| 146 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.86525106 |
| 147 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.85638698 |
| 148 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.82451345 |
| 149 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.82386790 |
| 150 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.81452854 |
| 151 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.81269325 |
| 152 | EWS_26573619_Chip-Seq_HEK293_Human | 0.80632625 |
| 153 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80354190 |
| 154 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.79752982 |
| 155 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.77525567 |
| 156 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.77360076 |
| 157 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.75576603 |
| 158 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.74910571 |
| 159 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.74502657 |
| 160 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.74345261 |
| 161 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.72808548 |
| 162 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.71874905 |
| 163 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.71717082 |
| 164 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.71466286 |
| 165 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.69981975 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 3.49226464 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.22068092 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.03234765 |
| 4 | MP0009840_abnormal_foam_cell | 2.97052093 |
| 5 | MP0001986_abnormal_taste_sensitivity | 2.92374733 |
| 6 | MP0003195_calcinosis | 2.87418550 |
| 7 | MP0006082_CNS_inflammation | 2.84354727 |
| 8 | MP0009785_altered_susceptibility_to | 2.71925396 |
| 9 | MP0009764_decreased_sensitivity_to | 2.71915462 |
| 10 | MP0005671_abnormal_response_to | 2.63151469 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.61002292 |
| 12 | MP0005167_abnormal_blood-brain_barrier | 2.47205429 |
| 13 | MP0003724_increased_susceptibility_to | 2.43622947 |
| 14 | MP0009697_abnormal_copulation | 2.33487624 |
| 15 | MP0005409_darkened_coat_color | 2.28082481 |
| 16 | MP0000372_irregular_coat_pigmentation | 2.27251518 |
| 17 | MP0001188_hyperpigmentation | 2.25157299 |
| 18 | MP0003763_abnormal_thymus_physiology | 2.17939201 |
| 19 | MP0003303_peritoneal_inflammation | 2.15743293 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.08879381 |
| 21 | MP0006292_abnormal_olfactory_placode | 2.06300312 |
| 22 | MP0002163_abnormal_gland_morphology | 2.04829136 |
| 23 | MP0002139_abnormal_hepatobiliary_system | 1.99567584 |
| 24 | MP0003950_abnormal_plasma_membrane | 1.98435816 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.98414059 |
| 26 | MP0003806_abnormal_nucleotide_metabolis | 1.95364136 |
| 27 | MP0002132_abnormal_respiratory_system | 1.95066944 |
| 28 | MP0003646_muscle_fatigue | 1.90768180 |
| 29 | MP0002933_joint_inflammation | 1.89375949 |
| 30 | MP0003136_yellow_coat_color | 1.88427277 |
| 31 | MP0005000_abnormal_immune_tolerance | 1.78688031 |
| 32 | MP0005025_abnormal_response_to | 1.75330969 |
| 33 | MP0008007_abnormal_cellular_replicative | 1.74664326 |
| 34 | MP0002638_abnormal_pupillary_reflex | 1.73966055 |
| 35 | MP0003186_abnormal_redox_activity | 1.68454006 |
| 36 | MP0005174_abnormal_tail_pigmentation | 1.68377728 |
| 37 | * MP0002420_abnormal_adaptive_immunity | 1.64483508 |
| 38 | MP0000015_abnormal_ear_pigmentation | 1.64076738 |
| 39 | MP0001542_abnormal_bone_strength | 1.63420598 |
| 40 | * MP0001819_abnormal_immune_cell | 1.61923353 |
| 41 | MP0002419_abnormal_innate_immunity | 1.61401423 |
| 42 | MP0005503_abnormal_tendon_morphology | 1.58856537 |
| 43 | MP0005387_immune_system_phenotype | 1.55151702 |
| 44 | MP0001790_abnormal_immune_system | 1.55151702 |
| 45 | MP0002452_abnormal_antigen_presenting | 1.54348286 |
| 46 | MP0002723_abnormal_immune_serum | 1.52377597 |
| 47 | MP0001905_abnormal_dopamine_level | 1.52021627 |
| 48 | MP0008875_abnormal_xenobiotic_pharmacok | 1.48295152 |
| 49 | MP0000569_abnormal_digit_pigmentation | 1.48215991 |
| 50 | MP0004510_myositis | 1.46169053 |
| 51 | MP0001853_heart_inflammation | 1.44643350 |
| 52 | MP0000681_abnormal_thyroid_gland | 1.44380317 |
| 53 | MP0002277_abnormal_respiratory_mucosa | 1.41322706 |
| 54 | MP0003011_delayed_dark_adaptation | 1.40600625 |
| 55 | MP0001800_abnormal_humoral_immune | 1.39690199 |
| 56 | MP0000685_abnormal_immune_system | 1.38978114 |
| 57 | * MP0009333_abnormal_splenocyte_physiolog | 1.36890044 |
| 58 | MP0002095_abnormal_skin_pigmentation | 1.35364558 |
| 59 | MP0005084_abnormal_gallbladder_morpholo | 1.33429934 |
| 60 | MP0002876_abnormal_thyroid_physiology | 1.33196374 |
| 61 | MP0002254_reproductive_system_inflammat | 1.33102986 |
| 62 | MP0005257_abnormal_intraocular_pressure | 1.30084597 |
| 63 | MP0005365_abnormal_bile_salt | 1.29808120 |
| 64 | MP0000604_amyloidosis | 1.29168598 |
| 65 | MP0002398_abnormal_bone_marrow | 1.28892484 |
| 66 | MP0002837_dystrophic_cardiac_calcinosis | 1.28792114 |
| 67 | MP0008058_abnormal_DNA_repair | 1.26713684 |
| 68 | MP0005075_abnormal_melanosome_morpholog | 1.26576940 |
| 69 | MP0003693_abnormal_embryo_hatching | 1.25459706 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 1.25192737 |
| 71 | MP0003436_decreased_susceptibility_to | 1.24409746 |
| 72 | MP0002396_abnormal_hematopoietic_system | 1.23909242 |
| 73 | MP0008469_abnormal_protein_level | 1.23468298 |
| 74 | MP0002405_respiratory_system_inflammati | 1.23307222 |
| 75 | MP0000716_abnormal_immune_system | 1.23207658 |
| 76 | MP0004134_abnormal_chest_morphology | 1.21385222 |
| 77 | MP0005310_abnormal_salivary_gland | 1.21192136 |
| 78 | MP0002938_white_spotting | 1.17963627 |
| 79 | MP0000049_abnormal_middle_ear | 1.17200202 |
| 80 | MP0002653_abnormal_ependyma_morphology | 1.16815368 |
| 81 | MP0002998_abnormal_bone_remodeling | 1.12068068 |
| 82 | MP0005379_endocrine/exocrine_gland_phen | 1.12043829 |
| 83 | MP0005551_abnormal_eye_electrophysiolog | 1.12033174 |
| 84 | MP0000858_altered_metastatic_potential | 1.10412745 |
| 85 | MP0003075_altered_response_to | 1.10408766 |
| 86 | MP0000490_abnormal_crypts_of | 1.09861257 |
| 87 | MP0001529_abnormal_vocalization | 1.09800713 |
| 88 | MP0000371_diluted_coat_color | 1.08871589 |
| 89 | MP0002429_abnormal_blood_cell | 1.06991477 |
| 90 | MP0000343_altered_response_to | 1.06897488 |
| 91 | MP0009250_abnormal_appendicular_skeleto | 1.06789160 |
| 92 | MP0005595_abnormal_vascular_smooth | 1.05494585 |
| 93 | MP0000689_abnormal_spleen_morphology | 1.05073730 |
| 94 | MP0010329_abnormal_lipoprotein_level | 1.04647043 |
| 95 | MP0010155_abnormal_intestine_physiology | 1.02644358 |
| 96 | MP0006036_abnormal_mitochondrial_physio | 1.00445766 |
| 97 | MP0010386_abnormal_urinary_bladder | 1.00389072 |
| 98 | MP0010368_abnormal_lymphatic_system | 0.99920933 |
| 99 | MP0005646_abnormal_pituitary_gland | 0.99901315 |
| 100 | MP0001533_abnormal_skeleton_physiology | 0.98862219 |
| 101 | MP0003191_abnormal_cellular_cholesterol | 0.98461578 |
| 102 | MP0002722_abnormal_immune_system | 0.98130914 |
| 103 | MP0000678_abnormal_parathyroid_gland | 0.97951401 |
| 104 | MP0008260_abnormal_autophagy | 0.97633143 |
| 105 | MP0003279_aneurysm | 0.97100615 |
| 106 | MP0005171_absent_coat_pigmentation | 0.96393307 |
| 107 | MP0000230_abnormal_systemic_arterial | 0.96266667 |
| 108 | MP0001324_abnormal_eye_pigmentation | 0.95956633 |
| 109 | MP0004147_increased_porphyrin_level | 0.94810480 |
| 110 | MP0002006_tumorigenesis | 0.94712315 |
| 111 | MP0001346_abnormal_lacrimal_gland | 0.94436927 |
| 112 | MP0003300_gastrointestinal_ulcer | 0.94177250 |
| 113 | MP0004142_abnormal_muscle_tone | 0.92335682 |
| 114 | MP0008438_abnormal_cutaneous_collagen | 0.92291680 |
| 115 | MP0000613_abnormal_salivary_gland | 0.92081799 |
| 116 | MP0005390_skeleton_phenotype | 0.90987145 |
| 117 | MP0002736_abnormal_nociception_after | 0.90871032 |
| 118 | MP0002160_abnormal_reproductive_system | 0.90032782 |
| 119 | MP0004782_abnormal_surfactant_physiolog | 0.89886451 |
| 120 | MP0004130_abnormal_muscle_cell | 0.89227439 |
| 121 | MP0005410_abnormal_fertilization | 0.87008628 |
| 122 | MP0001879_abnormal_lymphatic_vessel | 0.86166482 |
| 123 | MP0005645_abnormal_hypothalamus_physiol | 0.84479655 |
| 124 | MP0006054_spinal_hemorrhage | 0.82886326 |
| 125 | MP0003448_altered_tumor_morphology | 0.82878443 |
| 126 | MP0006276_abnormal_autonomic_nervous | 0.82244549 |
| 127 | MP0008932_abnormal_embryonic_tissue | 0.81010441 |
| 128 | MP0002332_abnormal_exercise_endurance | 0.80839319 |
| 129 | MP0000703_abnormal_thymus_morphology | 0.79008003 |
| 130 | MP0008004_abnormal_stomach_pH | 0.77811822 |
| 131 | MP0003828_pulmonary_edema | 0.77547333 |
| 132 | MP0004957_abnormal_blastocyst_morpholog | 0.77150476 |
| 133 | MP0009763_increased_sensitivity_to | 0.76789761 |
| 134 | * MP0001845_abnormal_inflammatory_respons | 0.76434893 |
| 135 | MP0005360_urolithiasis | 0.76230384 |
| 136 | MP0008057_abnormal_DNA_replication | 0.76192658 |
| 137 | MP0002735_abnormal_chemical_nociception | 0.75746465 |
| 138 | MP0004808_abnormal_hematopoietic_stem | 0.75003263 |
| 139 | MP0002166_altered_tumor_susceptibility | 0.73172059 |
| 140 | MP0005164_abnormal_response_to | 0.72393569 |
| 141 | MP0005464_abnormal_platelet_physiology | 0.71954746 |
| 142 | MP0005408_hypopigmentation | 0.70855348 |
| 143 | MP0001663_abnormal_digestive_system | 0.70492152 |
| 144 | MP0003786_premature_aging | 0.69631992 |
| 145 | MP0002751_abnormal_autonomic_nervous | 0.69336374 |
| 146 | MP0001873_stomach_inflammation | 0.68944696 |
| 147 | MP0000249_abnormal_blood_vessel | 0.68275777 |
| 148 | MP0003866_abnormal_defecation | 0.66958320 |
| 149 | MP0008877_abnormal_DNA_methylation | 0.66756032 |
| 150 | MP0005165_increased_susceptibility_to | 0.66294413 |
| 151 | MP0000427_abnormal_hair_cycle | 0.66125308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 6.65756371 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.65756371 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.65756371 |
| 4 | Type I transferrin isoform profile (HP:0003642) | 4.09527833 |
| 5 | Acute necrotizing encephalopathy (HP:0006965) | 4.08978816 |
| 6 | Increased cerebral lipofuscin (HP:0011813) | 4.08863932 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.99965881 |
| 8 | Mitochondrial inheritance (HP:0001427) | 3.92836687 |
| 9 | Hepatocellular necrosis (HP:0001404) | 3.92118600 |
| 10 | 3-Methylglutaconic aciduria (HP:0003535) | 3.75025218 |
| 11 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.67063934 |
| 12 | Dysostosis multiplex (HP:0000943) | 3.53255867 |
| 13 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.50931546 |
| 14 | Abnormal number of erythroid precursors (HP:0012131) | 3.49357564 |
| 15 | Aplastic anemia (HP:0001915) | 3.47925871 |
| 16 | Progressive macrocephaly (HP:0004481) | 3.32572046 |
| 17 | Hepatic necrosis (HP:0002605) | 3.29406159 |
| 18 | Reduced antithrombin III activity (HP:0001976) | 3.25864556 |
| 19 | Increased CSF lactate (HP:0002490) | 3.25734812 |
| 20 | Purpura (HP:0000979) | 3.21395097 |
| 21 | Stomatitis (HP:0010280) | 3.21249698 |
| 22 | Irregular epiphyses (HP:0010582) | 3.14818206 |
| 23 | Acute encephalopathy (HP:0006846) | 3.06943436 |
| 24 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.04374519 |
| 25 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.04374519 |
| 26 | Abnormal protein glycosylation (HP:0012346) | 3.04374519 |
| 27 | Abnormal glycosylation (HP:0012345) | 3.04374519 |
| 28 | Reticulocytopenia (HP:0001896) | 3.00693354 |
| 29 | Hypothermia (HP:0002045) | 2.97140824 |
| 30 | Abnormality of midbrain morphology (HP:0002418) | 2.95438758 |
| 31 | Molar tooth sign on MRI (HP:0002419) | 2.95438758 |
| 32 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.94426300 |
| 33 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.94426300 |
| 34 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.94426300 |
| 35 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.80926079 |
| 36 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.80926079 |
| 37 | Metaphyseal dysplasia (HP:0100255) | 2.78235161 |
| 38 | Renal Fanconi syndrome (HP:0001994) | 2.77663526 |
| 39 | Myositis (HP:0100614) | 2.76742035 |
| 40 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.74119817 |
| 41 | Systemic lupus erythematosus (HP:0002725) | 2.73581851 |
| 42 | Abnormality of macrophages (HP:0004311) | 2.72789728 |
| 43 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.72134305 |
| 44 | Patchy hypopigmentation of hair (HP:0011365) | 2.69172849 |
| 45 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.68812982 |
| 46 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.68542335 |
| 47 | Increased hepatocellular lipid droplets (HP:0006565) | 2.65532006 |
| 48 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.59933490 |
| 49 | Mutism (HP:0002300) | 2.59285308 |
| 50 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.56457864 |
| 51 | Mucopolysacchariduria (HP:0008155) | 2.56457864 |
| 52 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.56332133 |
| 53 | Metaphyseal irregularity (HP:0003025) | 2.51403598 |
| 54 | Exertional dyspnea (HP:0002875) | 2.49664603 |
| 55 | Hematochezia (HP:0002573) | 2.48551079 |
| 56 | Abolished electroretinogram (ERG) (HP:0000550) | 2.43433164 |
| 57 | Recurrent abscess formation (HP:0002722) | 2.41170920 |
| 58 | Exercise intolerance (HP:0003546) | 2.40392246 |
| 59 | Beaking of vertebral bodies (HP:0004568) | 2.35874670 |
| 60 | Congenital stationary night blindness (HP:0007642) | 2.33942978 |
| 61 | Increased serum lactate (HP:0002151) | 2.32530597 |
| 62 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.31691474 |
| 63 | Mesangial abnormality (HP:0001966) | 2.31605136 |
| 64 | Increased serum ferritin (HP:0003281) | 2.31335940 |
| 65 | Thrombocytosis (HP:0001894) | 2.29382037 |
| 66 | Increased IgM level (HP:0003496) | 2.28279129 |
| 67 | Prolonged bleeding time (HP:0003010) | 2.25902142 |
| 68 | Optic disc pallor (HP:0000543) | 2.25557442 |
| 69 | Flat capital femoral epiphysis (HP:0003370) | 2.25352750 |
| 70 | Albinism (HP:0001022) | 2.25311294 |
| 71 | Hypoplasia of the fovea (HP:0007750) | 2.24565820 |
| 72 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.23938476 |
| 73 | Parakeratosis (HP:0001036) | 2.23563570 |
| 74 | Severe visual impairment (HP:0001141) | 2.22715802 |
| 75 | Petechiae (HP:0000967) | 2.22270028 |
| 76 | Poor head control (HP:0002421) | 2.21541658 |
| 77 | Pulmonary infiltrates (HP:0002113) | 2.21396038 |
| 78 | True hermaphroditism (HP:0010459) | 2.20839858 |
| 79 | Pallor (HP:0000980) | 2.20014665 |
| 80 | Generalized aminoaciduria (HP:0002909) | 2.18765655 |
| 81 | Microvesicular hepatic steatosis (HP:0001414) | 2.15165280 |
| 82 | Lipid accumulation in hepatocytes (HP:0006561) | 2.14533095 |
| 83 | Spontaneous hematomas (HP:0007420) | 2.13767534 |
| 84 | Myocardial infarction (HP:0001658) | 2.13103117 |
| 85 | Respiratory failure (HP:0002878) | 2.12897258 |
| 86 | Optic neuritis (HP:0100653) | 2.12017349 |
| 87 | Retrobulbar optic neuritis (HP:0100654) | 2.12017349 |
| 88 | Type 2 muscle fiber atrophy (HP:0003554) | 2.11789383 |
| 89 | Conjunctival telangiectasia (HP:0000524) | 2.11131507 |
| 90 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.10598497 |
| 91 | Type II lissencephaly (HP:0007260) | 2.08876729 |
| 92 | Macrocytic anemia (HP:0001972) | 2.07212200 |
| 93 | Epiphyseal dysplasia (HP:0002656) | 2.06551319 |
| 94 | Ovoid vertebral bodies (HP:0003300) | 2.05989880 |
| 95 | IgM deficiency (HP:0002850) | 2.05574400 |
| 96 | Autoimmune thrombocytopenia (HP:0001973) | 2.04912037 |
| 97 | Abnormality of iron homeostasis (HP:0011031) | 2.04662085 |
| 98 | Congenital, generalized hypertrichosis (HP:0004540) | 2.02596182 |
| 99 | Genu varum (HP:0002970) | 2.02338759 |
| 100 | White forelock (HP:0002211) | 2.02007047 |
| 101 | Loss of speech (HP:0002371) | 2.00759679 |
| 102 | Hyperlipoproteinemia (HP:0010980) | 1.99274918 |
| 103 | Hypoproteinemia (HP:0003075) | 1.98963457 |
| 104 | Attenuation of retinal blood vessels (HP:0007843) | 1.98920862 |
| 105 | Prolonged neonatal jaundice (HP:0006579) | 1.97776353 |
| 106 | Xanthomatosis (HP:0000991) | 1.97751848 |
| 107 | Decreased central vision (HP:0007663) | 1.97216212 |
| 108 | Epistaxis (HP:0000421) | 1.96429386 |
| 109 | Pancreatic cysts (HP:0001737) | 1.96416231 |
| 110 | Nausea (HP:0002018) | 1.95543358 |
| 111 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.95422036 |
| 112 | Conical tooth (HP:0000698) | 1.94740458 |
| 113 | Recurrent pneumonia (HP:0006532) | 1.93789635 |
| 114 | Lactic acidosis (HP:0003128) | 1.93595899 |
| 115 | Tubular atrophy (HP:0000092) | 1.93175532 |
| 116 | Pancreatic fibrosis (HP:0100732) | 1.92770647 |
| 117 | Recurrent bacterial skin infections (HP:0005406) | 1.92192198 |
| 118 | Thyroid-stimulating hormone excess (HP:0002925) | 1.90407635 |
| 119 | Menorrhagia (HP:0000132) | 1.90248015 |
| 120 | Nephronophthisis (HP:0000090) | 1.88156970 |
| 121 | Orchitis (HP:0100796) | 1.87455136 |
| 122 | Increased intramyocellular lipid droplets (HP:0012240) | 1.87313211 |
| 123 | Abnormality of renal resorption (HP:0011038) | 1.86548288 |
| 124 | Abnormality of the fovea (HP:0000493) | 1.86050715 |
| 125 | Pancytopenia (HP:0001876) | 1.85815359 |
| 126 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.84085784 |
| 127 | Muscle fiber atrophy (HP:0100295) | 1.83424538 |
| 128 | Hemoptysis (HP:0002105) | 1.83015622 |
| 129 | Leukodystrophy (HP:0002415) | 1.82942970 |
| 130 | Disproportionate short-trunk short stature (HP:0003521) | 1.81201975 |
| 131 | IgG deficiency (HP:0004315) | 1.81168541 |
| 132 | Abnormality of the vertebral endplates (HP:0005106) | 1.80970334 |
| 133 | Irregular vertebral endplates (HP:0003301) | 1.79865551 |
| 134 | Abnormality of the femoral head (HP:0003368) | 1.79034386 |
| 135 | Microretrognathia (HP:0000308) | 1.78530282 |
| 136 | Abnormal tarsal ossification (HP:0008369) | 1.77043243 |
| 137 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.77009736 |
| 138 | Disinhibition (HP:0000734) | 1.76443150 |
| 139 | Abnormality of alanine metabolism (HP:0010916) | 1.75885517 |
| 140 | Hyperalaninemia (HP:0003348) | 1.75885517 |
| 141 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.75885517 |
| 142 | Tubulointerstitial fibrosis (HP:0005576) | 1.75503659 |
| 143 | Increased corneal curvature (HP:0100692) | 1.74609670 |
| 144 | Keratoconus (HP:0000563) | 1.74609670 |
| 145 | Vacuolated lymphocytes (HP:0001922) | 1.74416776 |
| 146 | Cardiomegaly (HP:0001640) | 1.73404607 |
| 147 | J-shaped sella turcica (HP:0002680) | 1.71258594 |
| 148 | Cerebral hemorrhage (HP:0001342) | 1.70478767 |
| 149 | Respiratory difficulties (HP:0002880) | 1.69340060 |
| 150 | Abnormality of the renal cortex (HP:0011035) | 1.68847094 |
| 151 | Axonal loss (HP:0003447) | 1.68841172 |
| 152 | Recurrent lower respiratory tract infections (HP:0002783) | 1.68155627 |
| 153 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 1.67903898 |
| 154 | Mediastinal lymphadenopathy (HP:0100721) | 1.67582482 |
| 155 | Neutropenia (HP:0001875) | 1.67209433 |
| 156 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.65189519 |
| 157 | Absent epiphyses (HP:0010577) | 1.65189519 |
| 158 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 1.64974389 |
| 159 | Abnormality of femoral epiphyses (HP:0006499) | 1.64974389 |
| 160 | Dry hair (HP:0011359) | 1.64726448 |
| 161 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.62896473 |
| 162 | Short femoral neck (HP:0100864) | 1.60941735 |
| 163 | Obstructive lung disease (HP:0006536) | 1.60149268 |
| 164 | Chronic obstructive pulmonary disease (HP:0006510) | 1.60149268 |
| 165 | Medial flaring of the eyebrow (HP:0010747) | 1.59217538 |
| 166 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.56267386 |
| 167 | Meningitis (HP:0001287) | 1.55690088 |
| 168 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.55262416 |
| 169 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.54381271 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK16 | 3.52952487 |
| 2 | NME2 | 3.35961627 |
| 3 | EIF2AK3 | 2.46291053 |
| 4 | PIM2 | 2.44527724 |
| 5 | VRK1 | 2.31438434 |
| 6 | FRK | 2.30911978 |
| 7 | TGFBR2 | 2.27856975 |
| 8 | TXK | 2.02490860 |
| 9 | MST4 | 1.95624390 |
| 10 | IRAK4 | 1.93652719 |
| 11 | CASK | 1.89303088 |
| 12 | ACVR1B | 1.88748469 |
| 13 | MUSK | 1.85902761 |
| 14 | TEC | 1.84356077 |
| 15 | MAP3K11 | 1.82795463 |
| 16 | ADRBK2 | 1.75623503 |
| 17 | PBK | 1.73316316 |
| 18 | NME1 | 1.72526250 |
| 19 | CDK8 | 1.69231273 |
| 20 | EIF2AK1 | 1.69217927 |
| 21 | IRAK3 | 1.67814310 |
| 22 | TAOK3 | 1.59633702 |
| 23 | BMPR1B | 1.58499864 |
| 24 | BUB1 | 1.54266499 |
| 25 | LIMK1 | 1.53541435 |
| 26 | TNIK | 1.48682344 |
| 27 | ADRBK1 | 1.47687838 |
| 28 | YES1 | 1.44026533 |
| 29 | BMPR2 | 1.42939472 |
| 30 | MYLK | 1.42406440 |
| 31 | CDK19 | 1.40720550 |
| 32 | MAP3K12 | 1.40376869 |
| 33 | TIE1 | 1.39375792 |
| 34 | MARK3 | 1.36677748 |
| 35 | ZAK | 1.35346020 |
| 36 | NLK | 1.31932355 |
| 37 | PRPF4B | 1.28123612 |
| 38 | MKNK1 | 1.27408783 |
| 39 | DAPK2 | 1.26454144 |
| 40 | MAPKAPK5 | 1.26167768 |
| 41 | PTK2B | 1.25112832 |
| 42 | DYRK2 | 1.24435584 |
| 43 | MAP3K14 | 1.23235845 |
| 44 | BCR | 1.22455176 |
| 45 | TESK2 | 1.21414208 |
| 46 | WNK4 | 1.20990884 |
| 47 | EIF2AK2 | 1.20010367 |
| 48 | BTK | 1.19480967 |
| 49 | ERBB3 | 1.18121101 |
| 50 | NUAK1 | 1.16913688 |
| 51 | ARAF | 1.14742993 |
| 52 | BCKDK | 1.13559524 |
| 53 | EPHB2 | 1.12526076 |
| 54 | NEK6 | 1.12441320 |
| 55 | KDR | 1.11709397 |
| 56 | TESK1 | 1.11304196 |
| 57 | MAPKAPK3 | 1.10864123 |
| 58 | SRPK1 | 1.10717461 |
| 59 | MATK | 1.09930277 |
| 60 | MAP2K7 | 1.08268682 |
| 61 | TLK1 | 1.07696041 |
| 62 | IKBKE | 1.06263057 |
| 63 | MKNK2 | 1.05968847 |
| 64 | IKBKB | 1.04252711 |
| 65 | TYRO3 | 1.00344502 |
| 66 | FGR | 0.98499604 |
| 67 | KIT | 0.98064513 |
| 68 | DDR2 | 0.96631692 |
| 69 | MOS | 0.94485562 |
| 70 | JAK3 | 0.92888845 |
| 71 | GRK1 | 0.92518064 |
| 72 | CAMKK2 | 0.91294177 |
| 73 | INSRR | 0.88464175 |
| 74 | WNK3 | 0.88285744 |
| 75 | SIK3 | 0.87179778 |
| 76 | ILK | 0.85275096 |
| 77 | TGFBR1 | 0.85266171 |
| 78 | GRK7 | 0.84638290 |
| 79 | MAPK13 | 0.84333774 |
| 80 | DAPK3 | 0.84247872 |
| 81 | TRPM7 | 0.83122604 |
| 82 | PIK3CG | 0.82864457 |
| 83 | STK3 | 0.82466465 |
| 84 | BRAF | 0.81912212 |
| 85 | MAP4K1 | 0.81323640 |
| 86 | SYK | 0.78438125 |
| 87 | CHUK | 0.78052006 |
| 88 | MAP2K6 | 0.77268652 |
| 89 | CLK1 | 0.76805431 |
| 90 | CSK | 0.75411163 |
| 91 | RIPK4 | 0.73384950 |
| 92 | MAP4K2 | 0.71878150 |
| 93 | BMX | 0.71340553 |
| 94 | TBK1 | 0.70918373 |
| 95 | LYN | 0.70861803 |
| 96 | MAP3K3 | 0.70765701 |
| 97 | PLK4 | 0.69422009 |
| 98 | DYRK3 | 0.67915694 |
| 99 | PKN1 | 0.65978356 |
| 100 | PINK1 | 0.65906832 |
| 101 | BRSK2 | 0.63703230 |
| 102 | PRKCQ | 0.62670576 |
| 103 | CDC42BPA | 0.62286713 |
| 104 | TAOK2 | 0.60468498 |
| 105 | LCK | 0.59692509 |
| 106 | RPS6KA4 | 0.58519682 |
| 107 | PRKCG | 0.56920431 |
| 108 | BLK | 0.56147471 |
| 109 | NEK9 | 0.54883621 |
| 110 | CSNK1G3 | 0.54506182 |
| 111 | STK39 | 0.52617782 |
| 112 | PRKG2 | 0.52415324 |
| 113 | OXSR1 | 0.52361260 |
| 114 | MAP3K9 | 0.51924871 |
| 115 | CDK3 | 0.51862977 |
| 116 | CSNK2A1 | 0.51126836 |
| 117 | ZAP70 | 0.50777594 |
| 118 | GRK6 | 0.50745294 |
| 119 | FLT3 | 0.49864499 |
| 120 | RPS6KA5 | 0.49691206 |
| 121 | IRAK1 | 0.47868006 |
| 122 | TNK2 | 0.46382635 |
| 123 | PLK3 | 0.45584965 |
| 124 | MAP2K3 | 0.44440907 |
| 125 | ABL1 | 0.43731643 |
| 126 | STK24 | 0.43570847 |
| 127 | GRK5 | 0.43101128 |
| 128 | IGF1R | 0.42490302 |
| 129 | PRKCD | 0.41718773 |
| 130 | TYK2 | 0.41203502 |
| 131 | ABL2 | 0.41064886 |
| 132 | TAOK1 | 0.40746324 |
| 133 | WEE1 | 0.40311729 |
| 134 | PIK3CA | 0.40161025 |
| 135 | PAK1 | 0.39791406 |
| 136 | PRKCE | 0.39556434 |
| 137 | MAPKAPK2 | 0.39418175 |
| 138 | EPHA3 | 0.38258821 |
| 139 | CAMK1D | 0.37899356 |
| 140 | FES | 0.36632665 |
| 141 | CSF1R | 0.36487962 |
| 142 | AURKA | 0.35816073 |
| 143 | DYRK1A | 0.35633346 |
| 144 | PIM1 | 0.35201185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.32639555 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.82994268 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.59827079 |
| 4 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.10609172 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.01140293 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 3.00834351 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.93191483 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.65343459 |
| 9 | DNA replication_Homo sapiens_hsa03030 | 2.62309557 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.51584404 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.44696742 |
| 12 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.34109213 |
| 13 | Mismatch repair_Homo sapiens_hsa03430 | 2.29730904 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 2.15331824 |
| 15 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.03393162 |
| 16 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.98993973 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.97185736 |
| 18 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.95831907 |
| 19 | Huntingtons disease_Homo sapiens_hsa05016 | 1.87612611 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.77857473 |
| 21 | Base excision repair_Homo sapiens_hsa03410 | 1.73087718 |
| 22 | Basal transcription factors_Homo sapiens_hsa03022 | 1.66102571 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.54836987 |
| 24 | Spliceosome_Homo sapiens_hsa03040 | 1.50537911 |
| 25 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.49690578 |
| 26 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.48263240 |
| 27 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.45096427 |
| 28 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.41483363 |
| 29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.33180817 |
| 30 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.32280538 |
| 31 | Purine metabolism_Homo sapiens_hsa00230 | 1.30818399 |
| 32 | Allograft rejection_Homo sapiens_hsa05330 | 1.30203267 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.26715721 |
| 34 | RNA degradation_Homo sapiens_hsa03018 | 1.25983763 |
| 35 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.24547235 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.20343388 |
| 37 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.19017984 |
| 38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.18410605 |
| 39 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.15018150 |
| 40 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.13765654 |
| 41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.11156311 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.09485560 |
| 43 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.09155569 |
| 44 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.08802161 |
| 45 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.05627451 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.05320517 |
| 47 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.03369796 |
| 48 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.02178858 |
| 49 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.01460947 |
| 50 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.00110537 |
| 51 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.99257229 |
| 52 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.98198741 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 0.97833818 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 0.97579690 |
| 55 | Malaria_Homo sapiens_hsa05144 | 0.97553371 |
| 56 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.97286188 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.96136715 |
| 58 | Measles_Homo sapiens_hsa05162 | 0.93242956 |
| 59 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.89918501 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 0.85692098 |
| 61 | Leishmaniasis_Homo sapiens_hsa05140 | 0.85417212 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.82685695 |
| 63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82157288 |
| 64 | Asthma_Homo sapiens_hsa05310 | 0.81620090 |
| 65 | Pertussis_Homo sapiens_hsa05133 | 0.81463463 |
| 66 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.79759084 |
| 67 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.78011046 |
| 68 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.76262463 |
| 69 | Mineral absorption_Homo sapiens_hsa04978 | 0.75441395 |
| 70 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.74327826 |
| 71 | Cell cycle_Homo sapiens_hsa04110 | 0.73941801 |
| 72 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.72948968 |
| 73 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.71775818 |
| 74 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71680138 |
| 75 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.70451094 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 0.68050183 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.67467326 |
| 78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.66736810 |
| 79 | RNA transport_Homo sapiens_hsa03013 | 0.66612731 |
| 80 | Platelet activation_Homo sapiens_hsa04611 | 0.65665879 |
| 81 | Salmonella infection_Homo sapiens_hsa05132 | 0.64874936 |
| 82 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.62090390 |
| 83 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.61364911 |
| 84 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.60249646 |
| 85 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59942984 |
| 86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.59018137 |
| 87 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56905305 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56351784 |
| 89 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.56221107 |
| 90 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55721803 |
| 91 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52216266 |
| 92 | Peroxisome_Homo sapiens_hsa04146 | 0.51836108 |
| 93 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51578570 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49106627 |
| 95 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.47393174 |
| 96 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.47332093 |
| 97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.47008703 |
| 98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.46998060 |
| 99 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45647379 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45604384 |
| 101 | Influenza A_Homo sapiens_hsa05164 | 0.44772821 |
| 102 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44207667 |
| 103 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42644888 |
| 104 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40102990 |
| 105 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.40050360 |
| 106 | Hepatitis B_Homo sapiens_hsa05161 | 0.38502493 |
| 107 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.38279177 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36357149 |
| 109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36041688 |
| 110 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.35572862 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34995448 |
| 112 | Apoptosis_Homo sapiens_hsa04210 | 0.34975107 |
| 113 | Bladder cancer_Homo sapiens_hsa05219 | 0.34654572 |
| 114 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.33521050 |
| 115 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.33364817 |
| 116 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.32715161 |
| 117 | Olfactory transduction_Homo sapiens_hsa04740 | 0.32572481 |
| 118 | Tuberculosis_Homo sapiens_hsa05152 | 0.29210621 |
| 119 | Phototransduction_Homo sapiens_hsa04744 | 0.29164096 |
| 120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.26607328 |
| 121 | Sulfur relay system_Homo sapiens_hsa04122 | 0.25473026 |
| 122 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.25093201 |
| 123 | HTLV-I infection_Homo sapiens_hsa05166 | 0.24961002 |
| 124 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.23126668 |
| 125 | Lysosome_Homo sapiens_hsa04142 | 0.21511697 |
| 126 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.20462097 |
| 127 | Thyroid cancer_Homo sapiens_hsa05216 | 0.19967803 |
| 128 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.18161415 |
| 129 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.17909759 |

